Medtronic, Inc. recalls
8 notices naming Medtronic, Inc. as the recalling firm, since June 18, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Medtronic, Inc.: OmniaSecure Model 3930M
Hazard (FDA): Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.
FDAMedical devices
Medtronic, Inc.: CareLink SmartSync Programmer and 2 more
Hazard (FDA): Software problem has the potential for an inaccurate displayed longevity estimate.
FDAMedical devices
Medtronic, Inc.: Medtronic Sphere-9 Catheter
Hazard (FDA): Ventricular fibrillation (VF) occurred during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac…
FDAMedical devices
Medtronic Inc: Abre Venous Self-Expanding Stent System
Hazard (FDA): Stents may be impacted by a Nitinol anomaly which causes a reduced stent diameter when deployed and corresponding reduced radial force. Issue may result in stent migration.
FDAMedical devices
Medtronic, Inc.: Aurora EV-ICD and Clinical EV-ICD
Hazard (FDA): There is a potential for delayed time to high-voltage (HV) therapy should a rare sequence of events occur.
FDAMedical devices
Medtronic, Inc.: Medtronic CareLink SmartSync Patient Connector and 1 more
Hazard (FDA): In prior SmartSync application versions, the Abort button stopped the test that was selected. During an induction test, there was a limited window of time for the user to abort a therapy, thereby limiting the user's…
FDAMedical devices
Medtronic, Inc.: Medtronic SmartLink Software loaded on SmartSync Patient Connector and 1 more
Hazard (FDA): A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a…
FDAMedical devices
Medtronic, Inc.: Azure S DR MRI SureScan
Hazard (FDA): Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac…
FDAMedical devices